AM Report Cat Hathaway 3/16/2010.  Proximal myalgia of the hip and shoulder girdles associated with morning stiffness (at least 1 hour)  Etiology is.

Slides:



Advertisements
Similar presentations
RHEUMATOID ARTHRITIS RA Inson lou. Epidemiology Symptoms signs Labs Diagnosis Treatment.
Advertisements

Author(s): Seetha Monrad, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Noncommercial–Share.
Atypical Polymyalgia Rheumatica
Vasculitis Syndromes Polymyalgia Rheumatica,Giant Cell Arteritis, Wegener’s Granulomatosis, Polyarteritis Nodosa.
Polymalgia Rheumatica
Erythrocyte sedimentation rate (ESR) is a non-specific test for inflammation. It is easy to perform, widely available, Inexpensive making it a widely.
Soft Tissue Rheumatism Gary Kunkel, M.D. Division of Rheumatology November, 2005.
Dr. Fahim Khan MBBS,MD,MRCP(UK),FRCPLondon,FRCP Edin, FACP Rheum CONSULTANT RHEUMATOLOGIST Aut Even Hospital, Kilkenny Whitfield Clinic Waterford,The St.
Case Presentation Lance C. Brunner M.D. Assistant Clinical Chief Department of Family Medicine.
Polymyalgia Rheumatica and Giant Cell Arteritis
Lananh Nguyen, M.D. Division of Neuropathology University of Pittsburgh Medical Center 72-year-old male with fever of unknown origin.
Polymyalgia Rheumatica (PMR) Temporal Arteritis (TA)
Achy shoulders and a very high CRP Sarah Tansley Rheumatology, Clinical Fellow.
Juvenile Rheumatoid Arthritis B. Paul Choate, M.D.
History of PMR 1888 First described as senile rheumatic gout (Bruce) 1936Secondary fibrositis 1945Periarthrosis humeroscapular 1946Peri-extra-articular.
Value of inflammatory markers Useful for diagnosis of inflammatory vs non inflammatory conditions Remember NON-SPECIFIC, increased in infection, inflammation,
detection of Rheumatoid factor by using LatexAgglutination
Joint Replacement Stephanie Arrington. Joint Replacement  Research suggests that more than a million people a year are getting a total joint replacement.
The Child With Joint Pain Diagnostic Clues
Diffuse Arthralgias and Myalgias High Impact Rheumatology.
Vasculitis and connective tissue disease – just a taster!! The common and the rare!!
Treatment of Rheumatoid Arthritis Then and Now
Giant Cell Arteritis&Polymyalgia Rheumatica
PMR & GCA Janet Pope Professor of Medicine Division of Rheumatology University of Western Ontario Polymyalgia Rheumatica (PMR) Giant-Cell Arteritis (GCA)
Diagnosis and Treatment of Aches and Pain in SLE
Dr. amal Alkhotani Frcpc neurology, epilepsy
C ASE PRESENTATION R HEUMATOLOGY U NIT Gur Chamutal MD.
Welcome to the Arthritis Foundation’s Introduction To Arthritis!
Nurse Practitioner Outreach Wrap up Janet Pope MD MPH FRCPC.
The evaluation and management of low back pain  Asgar Ali Kalla  Professor and Head  Division of Rheumatology  University of Cape Town.
Rheumatoid Arthritis Anila Malik GPVTS. Aims To cover the following: What is RA? Diagnostic criteria and clinical features Rheumatoid Factor Investigations.
Rheumatoid Arthritis(RA)
Giant cell arteritis and Polymyalgia rheumatica
NYU Medical Grand Rounds Clinical Vignette Monalyn R. Labitigan, M.D. PGY-3 November 17, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Orthopaedics Wa’el N. Qa’dan, MSc. Rheumatoid arthritis (RA): It is the commonest cause of chronic inflammatory joint disease. Most typical.
GIANT CELL ARTERITIS (Temporal or Cranial Arteritis)
Polymyalgia Rheumatica A micro-teach of BSR & BHPR guidelines
ABIM. 39 yo female evaluated for malar rash, arthralgias, and serositis. CBC and P2 are normal. ANA, anti-dsDNA, and anti-Smith antibodies are positive.
Case #13 Ellen Marie de los Reyes March 15, 2007.
March 22,  Most common organism?  Staph Aureus  Presentation?  Acute  Monoarthritis  Erythema  Warmth  Swelling  Intense pain.
NYU Medical Grand Rounds Clinical Vignette Joseph Shin, MD Tuesday, April 3, 2012 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Orthopedics Inflammatory Process Jan Bazner-Chandler RN, MSN, CNS, CPNP.
Teaching NeuroImages Neurology Resident and Fellow Section © 2013 American Academy of Neurology.
Giant Cell Arteritis Julie Story July 27, Overview Typical case presentation Differential diagnosis Confirming the diagnosis Associated symptoms.
Vasculitis Vasculitis arises when immune system mistakenly attacks blood vessels. What causes this attack isn't fully known, but it can result from infection.
Inflammatory Illnesses. Aims Appreciate the impact of inflammatory illnesses on patients’ lives Know how to identify and manage common inflammatory disorders.
Polymyalgia Rheumatica By: Tiffany Zumbahlen And Sedona Hilt.
Polymyglia Rheumatica Abbie & Kayla. What PMR is: o Polymyalgia Rheumatica (or PMR) is a syndrome that involves having intense pain in your muscles. Especially.
GOUT. Demographics Affects middle-aged to elderly men postmenopausal and elderly women (usually have OA and HPN causing mild renal insufficiency, and.
Adult Medical-Surgical Nursing Musculo-skeletal Module: Rheumatoid Arthritis.
Case Discussion Dr. Raid Jastania. What is the outcome of inflammation?
POLYMYALGIA RHEUMATICA
Rheumatoid Arthritis.
Yuliarni Syafrita Bagian Neurolog FK Unand
Dr. M.Sofi MD; FRCP (London); FRCPEdin; FRCSEdin.
POLYMYALGIA & GIANT CELL ARTERITIS
Polymyalgia Rheumatica & Giant-cell Arteritis
RHEUMATOID ARTHRITIS (RA). Introduction RA is a chronic, systemic inflammatory disorder of unknown etiology characterized by the manner in which it involved.
Juvenile Idiopathic arthritis and infectious arthritis 郭三元 Division of R-I-A TSGH.
POLYMYALGIA RHEUMATICA & GIANT CELL ARTERITIS
Acute Rheumatic Fever Prof . El Sayed Abdel Fattah Eid
POLYMYALGIA RHEUMATICA & GIANT CELL ARTERITIS
POLYMYALGIA RHEUMATICA & GIANT CELL ARTERITIS
3e Initiative 2009 How to investigate and follow-up Undifferentiated Peripheral Inflammatory Arthritis? Case 3 1.
POLYMYALGIA RHEUMATICA
Rheumatology for the GP
PMG Patient Information Evening
Giant Cell Arteritis and Polymyalgia Rheumatica Definition
Dr Sarah Levy Consultant Rheumatologist CUH
Algorithm based on the 2015 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) recommendations for the management of polymyalgia.
Presentation transcript:

AM Report Cat Hathaway 3/16/2010

 Proximal myalgia of the hip and shoulder girdles associated with morning stiffness (at least 1 hour)  Etiology is largely unknown  Associated with HLA-DR4  Associated with viral infection? ◦ viral infection resulting in monocyte activation  Some series show higher prevalence of antibodies to Adenovirus and RSV

 Elderly patients, >50 years of age ◦ Incidence 52.5/ ◦ Prevalence %  Females 2:1  White, european (highest rates in Northern Europe)  Some evidence of genetic susceptibility  50% Temporal arteritis patients will have PMR (15% of PMR patients will develop TA)

 Often previously healthy, >50  Bilateral proximal muscle pain and stiffness  ESR >40, CRP elevation  Prompt response to steroids  Low grade fevers, weight loss  Malaise, fatigue, depression  Difficulty getting out of bed, rising from sitting, performing ADLs  Rarely can have high spiking fevers

 Low grade temp  Can have LE swelling  Muscle strength is NORMAL  Pain specifically in shoulder and hip girdle despite lack of clinically significant swelling  Tenderness to palpation and diminished ROM in shoulders and hips  Can get a transient synovitis (usually knee, wrist, sternoclavicular joints)

 Rule out infectious/autoimmune process ◦ Endocarditis ◦ RA ◦ Lupus ◦ Systemic Infection ◦ Myositis  Low dose prednisone (10-15mg/d) for 2-4 weeks. Then can start trying to taper.  Vitamin D/Calcium  Steroid sparing agents (MTX, azathioprine)  NSAIDs

 Starting >10mg  fewer relapses, shorter treatment periods than compared to <10mg  Starting >15mg lead to higher cumulative doses and more steroid adverse affects  Tapering lead to more successful treatment, fewer relapses, when done slowly (1mg/mo)

 Overall, benign disease  Self limited and most resolve within 1-3 years, however patients experience significant decrease in quality of life  50-75% of patients can often be weaned off all steroids by 3 years ◦ If relapse, often occurs within 12 months of weaning steroids  Need to be monitored for TA

 Amyloidosis (inflammatory)  Fibromyalgia  Osteoarthritis  Shoulder disorders  Cervical spondylosis  Parkinson’s Disease  Multiple Myeloma

 ESR (typically >40, sometimes >100), CRP  ANA, RF, Blood cultures  CBC  CK  NORMAL!  Serum IL6 (not necessary, but will be elevated and often parallels disease course)  No imaging necessary but Xrays should not show erosive disease or osteopenia. ◦ MRI if done will often show bursitis and senovitis.  TA biopsy only done if you suspect TA

 Visual loss  Headache  Scalp tenderness  Jaw claudication  CVA  Aortic arch syndrome  Thoracic aorta aneurysm  Dissection

 Polymyalgia Rheumatica. Saad, Fioravanti, Samuels. Emedicine. Updated Aug 20, 2009  Arch Intern Med Nov 9;169(20): Treatment of PMR: a systematic review. Hernandez-Rodriguez.  Lancet Jul 19;372(9634): PMR and Temporal Arteritis. Salvarani et al.